期刊文献+

HPLC/MS考察大鼠和肝微粒体CYP450活性及硝苯地平代谢研究 被引量:6

Determination of in Vitro CYP450 Activity with Nifedipine as a Probe Drug by HPLC-MS
原文传递
导出
摘要 目的建立以硝苯地平为探针药物测定大鼠和犬肝微粒体活性的HPLC/MS。方法采用SHIMADZU VP-ODS(2.0mm×150mm,5μm)色谱柱;柱温为室温;以甲醇-水(55∶45)为流动相,流速:0.2mL·min-1。选择正离子扫描(SIM)m/z345。以硝苯地平为探针药物与大鼠或Beagle犬的肝微粒体进行体外孵育,以液相色谱串联质谱法测定硝苯地平的代谢产物氧化硝苯地平。结果在所建立的HPLC/MS条件下,硝苯地平的氧化产物保留时间约为7.15min。杂质峰不干扰测定;氧化硝苯地平最低检测限为3μg·L-1(S/N=3),线性范围为0.01~10mg·L-1,回收率及精密度均符合检测要求。结论该HPLC/MS能够准确的检测出在大鼠和Beagle犬肝微粒体中的硝苯地平氧化产物。 OBJECTIVE To establish a HPLC/MS method to determine microsomes activity in vitro using nifedipine as a probe drug. METHODS Nifedipine was incubated with rat or Beagle dog liver microsomes in vitro, oxidized nifedipine were determined by HPLC-MS. A SHIMADZU-ODS (2.0 mm× 150 mm) column as chromatographic column. The mobile phase consisted of methanol-water (55 : 45) at a flow rate of 0.2 mL·min^-1. MS detector was set as positive selective ion scan mode at m/z 345. RESULTS The retention time of oxidized nifedipine was 7.15 rain. The detection limit in rat or Beagle dog liver microsomes was 3 μg·L^-1 for oxidized nifedipine (S/N=3), and the linear range was over the range of 0.01-10 mg·L^-1. The recovery and accuracy satisfied the requirement of detection for oxidized nifedipine in rat and Beagle dog liver microsomes. CONCLUSION Oxidized nifedipine can be detected accurately and precisely by using the HPLC/MS method.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第7期506-509,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金重点资助项目(30730110) 陕西省自然科学基金资助项目(2006C221)
关键词 HPLC/MS 硝苯地平 肝微粒体 HPLC/MS nifedipine microsomes
  • 相关文献

参考文献16

  • 1LENG X F, QIU X H. The Structure Function and Applying Prospect of Cytochrome P450(细胞色素P450酶系的结构、功能与应用前景)[M]. Beijing: Beijing Science Press, 2001: 56-75. 被引量:1
  • 2The group of the guard of un-clinic pharmaclkinetic of chemical drug. The Guard of Un-Clinic Pharmaclkinetic of Chemical Drug(化学药物非临床药代动力学研究技术指导原则)[M]. Beijing: SFDA, 2005: 21. 被引量:1
  • 3PATKI K C, VON MOLTKE L C, GREENBLATT D J. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochomes P450: role of CYP3A4 and CYP3A5 [J]. Drug Metab Dispos, 2003, 31(7): 938-944. 被引量:1
  • 4戴春岭,李苏,梁永钜,廖海,闫琳,符立梧.建立一种测定细胞色素P450 3A4活性的方法[J].中国药学杂志,2006,41(18):1420-1423. 被引量:5
  • 5WILLIAMS J A, RING B J, CANTRELL V E, et al. Comparative metabolic capabilities of CYP3A4,CYP3A5, and CYP3A7[J]. Drug Metab Dispos, 2002, 30(8): 883-891. 被引量:1
  • 6SHIMADA T, GUENGERICH F E Evidence for cytochrome P-450NF. the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver [J]. Biochemistry, 1989, 86(2): 462-465. 被引量:1
  • 7NIWA T, KANEKO H, NARITOMI Y, et al. Species and sex differences of testosterone and nifedipine oxidation in liver microsomes of rat, dog and monkey [J]. Xenobiotica, 1995, 25(10): 1041-1049. 被引量:1
  • 8ZUBER R, ANZENBACHEROVA E, ANZENBACHER P. Cytochromes P450 and experimental models of drug metabolism [J]. J Cell Mol Med, 2002, 6(2): 189-198. 被引量:1
  • 9GUENGERICH F, MARTINMV, BEAUNE P H, et al. Characterization of rat and human liver microsomal cytochrome P450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism [J]. J Biol Chem, 1986, 261(11): 5051-5055. 被引量:1
  • 10赵娜萍,余露山,姚彤炜,曾苏.高效液相色谱法测定人肝微粒体中帕洛诺司琼的浓度[J].中国药学杂志,2006,41(21):1654-1656. 被引量:4

二级参考文献28

  • 1王秀文,丁岩,梁永钜,陈黎明,石智,杨小平,古练权,符立梧.FG020326通过增加泰素帝介导caspase-8和3激活的敏感性克服多药耐药细胞MCF-7/ADR的凋亡抗性[J].癌症,2004,23(z1):1379-1385. 被引量:10
  • 2毕惠嫦,陈孝,黄民.肝脏灌流技术及其在药物研究中的应用进展[J].中国药理学通报,2004,20(9):968-971. 被引量:8
  • 3徐凯建,张慧君,陆义诚,吴琳华,孙考祥,胡君茹.心痛定片剂与滴丸的人体生物利用度及药代动力学的研究[J].中国医院药学杂志,1994,14(3):106-108. 被引量:4
  • 4Minami J,Numabe A,Andoh N.et al.Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension[J].British Journal of clinical Phamacology,2004,57(5):632. 被引量:1
  • 5Troger U, Martens J, Meyer FP, et al. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses [ J ]. Arzneimittelforschung, 1995,45(12):1266. 被引量:1
  • 6Dankers J,van den Elshoud J, Ahr G, et al. Determination of nifedipine in human plasma by flow-injection tandem mass spectrometry[ J]. J Chromatogr B Biomed Sci Appl, 1998,710(1-2):115. 被引量:1
  • 7ZHOU J Q,TANG Z Q.Cytochrome P450 directed prodrug activation therapy in the research of cancer e nzyrnology[J].J Chin Pharm Sci,2005,14(1):1-9. 被引量:1
  • 8VUPPUGALA R,SHAH R B,CHIMALAKONDA A P,et al.Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin[J].Pharm Res,2003,20(1):81-88. 被引量:1
  • 9JOURDAN M,VAUBOURDOLLE M,CYNOBER L,et al.Effect of aging on liver functions--an experimental study in a perfused rat liver model[J].Exp Gerontol,2004,39 (9):1341-1346. 被引量:1
  • 10ZHOU J Q,TANG Z Q.An evaluation of quercetin,a natural phyto-estrogen,effect on rat CYP1A2,CYP2E1,CYP3A2 and microsomal oxidative activities from in vitro liver microsome metabolism[J].J Chin Pharm Sci,2005,14(4):231-236. 被引量:1

共引文献19

同被引文献45

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部